Myriad Genetics (MYGN)'s 30-day implied volatility (IV30) was 69.7% at the close on November 11, 2026, down from 71.8% the day before, against a 52-week range of 37.2% to 128.2%. Its 20-day historical volatility was 78.4%.
Data as of November 11, 2026.